By Jillian Caldwell, MS, PA-C
Neurotoxins | 9 min read | Published 2026-05-15
Jeuveau vs Botox vs Dysport: which one is right for you?
Patients often ask whether one of these products is "better" than the others. The honest answer is that they are different tools that work the same way mechanistically, and the choice between them is more about your specific anatomy and timeline than about one being broadly superior.
I carry Jeuveau and Dysport at MV. I do not carry Botox brand specifically, but I have used it extensively in training and earlier practice, and I will discuss it here because most patients searching for "Botox" mean the category, not the brand.
Same drug class, three different products
All three are botulinum toxin type A - the same active compound, working by the same mechanism. Each is purified and formulated slightly differently by its manufacturer:
- Botox (onabotulinumtoxinA) - Allergan/AbbVie. FDA-approved for aesthetic use since 2002. The longest U.S. market history.
- Dysport (abobotulinumtoxinA) - Galderma. FDA-approved in the U.S. since 2009. Has been used globally since the 1990s.
- Jeuveau (prabotulinumtoxinA-xvfs) - Evolus. FDA-approved in 2019. Sometimes called "Newtox." The newest of the three on the U.S. market.
All three relax the muscle they are injected into. Done well, they soften dynamic lines (the lines that show when you move your face) and gradually fade static lines (the lines that stay when you are not moving). Done poorly, all three can produce the same overdone or asymmetric look.
Where they actually differ
Onset speed
Dysport tends to onset fastest - patients commonly see early effect at day 2 or 3 and full effect by day 7 to 10. Jeuveau is close, with early effect at 2 to 4 days. Botox is the slowest of the three to kick in, typically 5 to 7 days for early effect.
This matters when treatment timing is event-driven. A patient with a wedding in 10 days who has never used neurotoxin before is a Dysport candidate by default. The faster onset gives us a margin if anything needs adjustment.
Diffusion - how much the product spreads from the injection point
Dysport diffuses slightly more than Botox or Jeuveau. Each injection point treats a slightly broader area. This is useful when treating broader muscles like the frontalis (forehead) where you want even coverage. It is something to be careful about in precise small-area work near the brow, where you do not want the product spreading into the eyelid muscle (orbicularis oculi) and causing eyelid droop.
Jeuveau and Botox tend to stay closer to the injection point. Better for precise small-area work like lip flips, brow tail adjustments, and bunny-line treatment.
Unit conversion
This is where conversations get confused. Units are not interchangeable across products. Roughly:
- Botox to Jeuveau: approximately 1:1. If you were comfortable on 20 units of Botox for your glabella, you are likely comfortable on 20 units of Jeuveau.
- Botox to Dysport: approximately 1:2.5 to 1:3. If you were on 20 units of Botox for your glabella, you would need roughly 50 to 60 units of Dysport.
The per-unit price is also different. Dysport units are smaller and priced lower per unit, but you need more of them. Total cost per treatment area tends to come out roughly comparable across products.
Duration
Clinical data and my own observation: roughly comparable across the three for most patients. 3 to 4 months for upper-face work. Some patients metabolize one product faster than another, which is one of the reasons to occasionally try switching if you feel like a current product is not lasting as long as it used to.
How I pick between Jeuveau and Dysport at MV
In honest practice, the choice is often driven by patient preference once I have walked through the differences. A few defaults I use when patients ask me to pick:
- First-time patient with an event in 10 to 14 days: Dysport, for the faster onset and the margin to adjust.
- Precise small-area work like a lip flip, a brow tail tweak, or DAO treatment: Jeuveau, for the tighter diffusion radius.
- Forehead with broad even coverage needed: Either works. I tend toward Dysport when the frontalis is wide.
- Patient who has done Botox elsewhere and felt the result took too long to kick in: Worth trying Dysport once to compare.
- Patient who has done Botox elsewhere and felt the result was patchy or moved into eyelid: Worth trying Jeuveau once for the tighter diffusion profile.
The product I will not pick: Daxxify
Daxxify (daxibotulinumtoxinA) is the fifth neurotoxin in this class, FDA-approved in 2022 by Revance. The pitch is longer duration - the manufacturer suggests 6 months versus the 3 to 4 months of the others. The clinical data is more mixed than the marketing suggests, and my real-world experience and what I read from injectors I trust is that Daxxify produces a longer but less predictable result. I do not carry it currently. The patients I see who have tried it have mostly come back wanting Jeuveau or Dysport.
Switching between products
Most patients can switch between Jeuveau, Dysport, and Botox without issue. We convert your previous dose to the new product's equivalent units and we see each other at the two-week follow-up to assess. Some patients respond better to one product than another - that is information we want.
The honest summary
Same drug class. Three similar products with small but real differences in onset, diffusion, and unit dosing. The choice between them is more about your face and your timeline than about one being better than the others. Most patients do well on whichever product their trusted injector picks based on the situation.
Related at MV
Have questions about this?
Book a consultation with Jillian and we will walk through it together.
Book a Consultation(opens in a new tab)